Symphoricarpus racemosus - analogs
| Prices in pharmacies: — Instructions Symphoricarpus racemosus | |||||||||
|
ⓘ✘Enter drugs for checking interactions through a quick button search . |
|
ⓘ✘ diseases to evaluate contraindications and side effects through a quick search. | ||||||
Начиная работу с сервисом, вы принимаете соглашение пользователя. Kiberis do not replace the doctor!
- 19% 1-5€ Cerium oxalicum
- 16% — Coqueluchinum
- 15% 1.9-17.8€ Pertussinum
- 15% — Clerodendron infortunatum
- 14% 1-5€ Apomorphini hydrochloridum
- 14% 1-13.8€ Achyranthes aspera
- 14% — Helleborus orientalis
- 14% 1-5€ Alstonia constricta
- 13% 1-13.8€ Populus tremuloides
- 13% — Cetraria islandica
- 13% — Helleborus viridis
- 13% 1-13.8€ Canchalagua
- 12% — Agrostemma githago
- 12% — Andersonia
- 12% 1-5€ Serpentaria aristolochia
- 12% — Guatteria gaumeri
- 12% — Mercurius sulphocyanatus
- 12% — Prinos verticillatus
- 11% 1-13.8€ Acalypha indica
- 11% 1-5€ Agaricus emeticus
- 11% — Kousso
- 11% — Tannicum acidum
- 11% — Illicium
- 11% 1.6-12€ Kali sulphuratum
- 10% 1-13.8€ Saponaria officinalis
- 10% 1-13.8€ Leonurus cardiaca
- 10% — Latrodectus haselliti
- 10% — Cadmium bromatum
- 10% 1-5€ Euonyminum
- 10% 1-5€ Ficus religiosa
- 10% — Nyctanthes arbor tristis
- 10% 1-5€ Eupatorium aromaticum
- 10% — Sium latifolium
Learn more about the selection of analogues
- The drug has «Symphoricarpus racemosus» no complete analogues; 34 analogs by action, the most similar - Cerium oxalicum (1-5€).
- Medical online service has selected the best substitutes for Symphoricarpus racemosus based on its instructions, components, pharmaceutical groups and practical application.
- The table shows the prices of Symphoricarpus racemosus analogues to choose the cheapest pills.
- If you have introduced other drugs for registration, substitutes are selected taking into account the assessment of interactions and safety.
- Sometimes, due to the presence of dangerous interactions, it is necessary to use drugs that are similar in effect, sometimes even from different pharmacological groups.